bioRxiv · 10.1101/289603
Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis
Abstract
Signaling pathway models are largely based on the compilation of literature data from heterogeneous cellular contexts. Indeed, de novo reconstruction of signaling interactions from large-scale molecular profiling is still lagging, compared to similar efforts in transcriptional and protein-protein interaction networks. To address this challenge, we introduce a novel algorithm for the systematic inference of protein kinase pathways, and applied it to published mass spectrometry-based phosphotyrosine profile data from 250 lung adenocarcinoma (LUAD) samples. The resulting network includes 43 TKs and 415 inferred, LUAD-specific substrates, which were validated at >60% accuracy by SILAC assays, including \"novel substrates of the EGFR and c-MET TKs, which play a critical oncogenic role in lung cancer. This systematic, data-driven model supported drug response prediction on an individual sample basis, including accurate prediction and validation of synergistic EGFR and c-MET inhibitor activity in cells lacking mutations in either gene, thus contributing to current precision oncology efforts.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Bansal, M., Peyton, M., He, J., Kaustagi, M., Iyer, A., Comb, M., White, M., Minna, J., Califano, A.. 2018-03-29. Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis. https://doi.org/10.1101/289603
Cite the original work for its findings. Save a collection to share your selection of sources.